Infectious Diseases News
Spread the word about the latest research, updates, products, services and treatment advances regarding infectious diseases. This section covers information about diseases caused by bacteria, viruses, fungi or parasites, of interest to clinicians, scientists, patients and medical and pharmaceutical industry professionals.
Pediatrician Accreditation Pilot to Improve HPV Vaccination Rates
Research shows the HPV vaccine prevents cancer, and preteens can be protected by strong provider recommendation. Enrollment is now open for pediatricians in Illinois and Wisconsin for an accredited quality improvement project to increase vaccination rates, and participants can register on an individual basis or by practice. - May 24, 2018 - Wisconsin Chapter, American Academy of Pediatrics
Presbyterian/St. Luke’s Successfully Completes 4,000th Blood & Marrow Transplant Since Inception of Program
The Colorado Blood Cancer Institute (CBCI), in partnership with Sarah Cannon Cancer Institute (Sarah Cannon) at HealthONE’s Presbyterian/St. Luke’s Medical Center (P/SL), successfully completed its 4,000th blood and marrow, or stem cell, transplant since the inception of the program in... - May 11, 2018 - Presbyterian/St. Luke's Medical Center
Revolutionizing Infection Control: Visa Lighting Announces Partnership with Vital Vio
What happens when groundbreaking technology meets industry leadership? This spring, healthcare solutions company Vital Vio and lighting manufacturer Visa Lighting will introduce LED disinfection technology to a wide range of applications. Collaboration has always been the creative approach that... - April 10, 2018 - Visa Lighting
Leona W. Ayers, M.D. Honored as a Woman of Distinction by P.O.W.E.R. (Professional Organization of Women of Excellence Recognized)
Leona W. Ayers, M.D. of Dublin, Ohio has been honored as a Woman of Distinction for the second quarter of 2018 by P.O.W.E.R. (Professional Organization of Women of Excellence Recognized) for her outstanding achievements and high level of success in the field of education. Each quarter P.O.W.E.R. - April 06, 2018 - P.O.W.E.R. Professional Organization of Women of Excellence Recognized
New Day Explores OSHA’s New Silica Regulation at AGC Construction Risk Management Conference
Jeff Slivka, president of New Day Underwriting Managers LLC, recently explored the ripple effects of OSHA’s new silica standard on the legal, insurance, and construction environments at the 2018 Conference on Surety Bonding & Construction Risk Management. Hosted by the Associated General... - February 13, 2018 - R-T Specialty, LLC's Environmental & Construction Professional Practice
MD Now Recommends Anti-Viral Treatment for Severe Flu Season in South Florida
The CDC has reported a sharp increase in influenza activity in the U.S. in recent weeks, with South Florida hit particularly hard due to an influx of winter travelers. To curb complications from the virus, MD Now is offering prescriptions for antiviral medications as appropriate, at all 33 South... - February 04, 2018 - MD Now Urgent Care
Discover Novel Based Vial Based Technology, Presented by Roche This May at SMi's Injectable Drug Delivery
Building on the success of SMi's 10th Annual Flagship Conference Pre-Filled Syringes, SMi are thrilled to present the launch of their Injectable Drug Delivery conference being held at Holiday Inn, Kensington Forum, London, on the 16th – 17th May 2018. Their global panel of speakers will... - January 25, 2018 - SAE Media Group
Review the Successes of 2017 and Look to the Future of AMR
Christopher Houchens of BARDA talks about Incentivizing Antibacterial Research and Development SMi’s Superbugs & Superdrugs Conference 2018 - January 03, 2018 - SAE Media Group
MHRA Update: Regulatory Considerations for the Registration of New Antibacterial Agents
MHRA to provide news updates on regulatory considerations at 20th annual “Superbugs” summit. - December 15, 2017 - SAE Media Group
GeneFluidics Announces CE-IVD Marking of UtiMax™ Uropathogen Identification (ID) and Antimicrobial Susceptibility Testing (AST)
GeneFluidics, a molecular diagnostics company specializing in the development of diagnostics solutions for infectious diseases, today announced CE marking for UtiMax™ under the Directive 98/79/EC on in vitro diagnostic medical devices. UtiMax™has successfully completed a multicenter validation study and clinical testing. It does not require clinical isolates from urine cultures, enabling a rapid ID reporting in as short as 30 minutes and AST in 120 minutes for a positive ID result. - December 10, 2017 - GeneFluidics Inc.
Superbugs: Exclusive Interviews Released with ABAC Therapeutics, Alchemy Biomedical and Oppilotech
SMi Reports: Expert insight into tackling the scientific, regulatory and economic challenges to combat antimicrobial resistance. - November 24, 2017 - SAE Media Group
ACT Inc. Marks 61st Anniversary with Free Human Interest Column Offered to Media
A new consumer-interest column is being offered free to the media by the founder of a multi-media marketing company to mark the 61st anniversary of ACT., Inc, Philadelphia. The article is headlined “Handicapped? Using a walker has its benefits. Like Walking!” The author is Joe Ball,... - October 28, 2017 - ACT, Inc.
Working KnowledgeCSP Awarded International Knowledge Management Consulting Services Contract from The Global Fund to Fight AIDS, Tuberculosis and Malaria
Working KnowledgeCSP (WK), a recognized US and international provider of knowledge management solutions, announced a competitive contract award for Knowledge Management (KM) Consulting Services Contract from The Global Fund to Fight AIDS, Tuberculosis and Malaria, headquartered in Geneva,... - October 27, 2017 - Working Knowledge CSP
"The Persistent Spiral" - New e-Book by Lyme Activist M.M. Drymon Reveals Ancient History of Lyme Disease Infections
M.M. Drymon releases new e-Book "The Persistent Spiral." - October 27, 2017 - M. M. Drymon
Antibiotic Drug Experts + Senior Industry Leaders Set to Gather at Superbugs USA
SMi Group will open doors in 3 weeks to host the next annual USA Superbugs summit when it returns to Iselin, New Jersey on Nov 13th – 14th. www.superbugs-usa.com/prc Following over two decades of expertise in Europe, the USA show will gather senior industry experts to delve deeper into core... - October 25, 2017 - SAE Media Group
The Solution Containment Announces Sale for Infection Prevention Week
Save big on The Solution HEPA-filtered Mobile Containment Units during Infection Prevention Week from October 15-21. - October 11, 2017 - Prevent Life Safety
Superbugs USA: BARDA, CARB-X, Big Pharma and Biotech Present New Updates on Antimicrobial Resistance
SMI REPORTS: Industry meeting on antimicrobial resistance returns to Iselin, New Jersey this fall. - October 09, 2017 - SAE Media Group
How is the Medical Industry Still Trying to Overcome Antibacterial Resistance?
SMi Reports: Superbugs & Superdrugs USA returns to Iselin, New Jersey on 13th and 14th November 2017. - October 02, 2017 - SAE Media Group
MappBio Announces Contracts with BARDA for ZMapp and Additional Filovirus Medical Countermeasures
Mapp Biopharmaceutical, Inc., announced today that it has been awarded a Project BioShield contract (HHSO100201700017C) of approximately $46 million by The Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at... - September 30, 2017 - Mapp Biopharmaceutical, Inc.
The Use of Animal Models in Pre-Clinical Drug Development
UNT Health Science Centre to lead interactive workshop at the next annual USA meeting on Superbugs and Superdrugs. - September 21, 2017 - SAE Media Group
New Children’s Book About Boogers Poised to Reduce Germs, Save Desks and Sleeves
"Where a Booger Goes," Andrews’ first book (set for release by Black Swan Publishing, LLC on 10/21/2017), highlights inappropriate booger-disposal habits by several cartoon children before reaching the conclusion of where a booger truly belongs. The illustrated boogers in the book are full of character and personality, and manage to be disgusting and adorable at the same time. - September 13, 2017 - Black Swan Publishing, LLC
Motif Biosciences Unveil Novel Solutions for the Treatment of Deadly Superbugs
New Interview Out with Motif Biosciences in the run up to their keynote address at Superbugs & Superdrugs USA this Fall. - September 12, 2017 - SAE Media Group
Antibiotics Update: 3 Discovery Projects to Tackle MDR Gram-Negative Pathogens
Tim Opperman, Senior Research Scientist from Microbiotix, unveils new updates at SMi's next Annual Superbugs and Superdrugs USA Summit. - July 13, 2017 - SAE Media Group
Africa Water Wells Fundraising for 2 Additional Water Wells for 2 Schools for the Deaf in Sotik, Kenya
Africa Water Wells, founded by Sandy & Bud Mulcahy, has expanded their mission beyond clean water to include free AA and medical care, women's empowerment programs, and donated used laptops to primary schools in and around Sotik. They are now fundraising for additional water wells including two for Schools for the Deaf without access to clean water in Sotik, Kenya. - July 12, 2017 - Lee Mulcahy
Coppe Laboratories Announces Powassan Virus Co-Infection Research in Wisconsin Lyme Patients
Coppe Laboratories conducted patient testing research in Wisconsin among 95 Lyme suspected patients. Within the 95 patient cohort, 41 were tested positive for Lyme disease. Of the 41 tested positive it was demonstrated in the research that approx. 17% of patients were also positive for Powassan Virus. - July 11, 2017 - Coppe Laboratories
CARB-X Exclusive: Chief Strategy Officer John Rex to Open Superbugs USA Summit
Infectious disease specialist John Rex will open SMi’s next annual show on antimicrobial resistance when it returns to North America this fall. BARDA, Pfizer, Visterra and ContraFect also included on the notable speaker line-up for 2017. - June 22, 2017 - SAE Media Group
Self Care Catalysts and SAGE Launch “SAGE Health Storylines” on HIV Long-Term Survivors Awareness Day
The SAGE Health Storylines self care app was designed in partnership with SAGE & Self Care Catalysts to support the health and well being of older adults within the LGBT community. Please help spread the word and support the health and well being of the diverse senior community. - June 09, 2017 - Self Care Catalysts
G&l Scientific Inc. Announces Its Expansion Into Regulatory Affairs, Complementing Its Industry-Leading Clinical Research Offering
G&L Scientific Inc, a company founded by Peter Griffin and Stephen Loughrey, who together built Pharmalink Consulting into the leading, independent Regulatory Affairs specialist, today announced their intention to once more provide Regulatory Affairs services to life-science clients. G&L... - June 02, 2017 - G&L Scientific Inc
Hepatitis E Diagnostic Tests Market by Test Types, End Users, Growth Trends and Forecast to 2021, Upcoming Report by iHealthcareAnalyst, Inc.
Hepatitis E Diagnostic Tests Market by Test Type (ELISA HEV IgM Test Kits, ELISA HEV IgG Test Kits, RT-PCR Test Kits, Others), End Users (Diagnostic Laboratories, Hospitals, Point-of-Care) and Forecast 2017-2021. - April 30, 2017 - iHealthcareAnalyst, Inc.
17 Y/O CEO Revolutionizes STD Testing in Major US Cities
Xavier A. Baruti inspires his 9 employees to meet people where they live...at home. Baruti heads up the Atlanta, Georgia based Get Well Mobile STD Screening LLC to slow the increasing rate of STDs in the city. Baruti reports wanting to make STD testing quick, affordable and convenient for the 5.6... - April 24, 2017 - Get Well Mobile STD Screening
EMLab P&K’s Chicago Laboratory Now AIHA-LAP, LLC Accredited for Legionella Analysis
EMLab P&K’s microbiology laboratory in Chicago, Illinois receives accreditation from AIHA-LAP, LLC for Legionella testing. EMLab P&K continues expanding its Legionella analysis capacity nationwide. - April 07, 2017 - EMLab P&K IAQ Laboratory
Global Lateral Flow Disease Testing Market by Applications, End Users, Growth Trends and Forecast to 2020, New Research by iHealthcareAnalyst, Inc.
Lateral Flow Disease Testing Market by Application (Hepatitis, HIV, Influenza, Malaria, Pregnancy, Syphilis), and End Users (Hospitals, Home Testing, Community Testing, Laboratory Testing) 2016-2020 - March 30, 2017 - iHealthcareAnalyst, Inc.
Global Hospital-Acquired Infection Therapeutics Market by Indications, Drugs, Clinical Pipeline, and Forecast to 2020, New Research by iHealthcareAnalyst, Inc.
Hospital-Acquired Infection Therapeutics Market by Drug Type (Antibacterial, Antifungal and Antiviral Drugs), Clinical Pipeline Analysis of Phase 1, 2 and 3 Drugs (Amikacin Inhale, CAZ AVI Ceftolozane, Dalvance, Delafloxacin, Eravacycline, MK-3415A, Oritavancin, Plazomicin, Surotomycin, Tedizolid), and Indications (Blood Stream Infections, Gastrointestinal Disorders, HAP, SSIs, UTIs) 2016-2020 - March 08, 2017 - iHealthcareAnalyst, Inc.
Global Hospital Acquired Disease Testing Market by Infection Type, Diagnostic Tests, Growth Trends and Forecast to 2020, New Findings by iHealthcareAnalyst, Inc.
Hospital Acquired Disease Testing Market by Test Type (Blood Stream Associated Infection, MRSA Infection, Hospital-Acquired Pneumonia, Surgical Associated Infection, UTI, Gastroenteritis, Puerperal Fever) 2016-2020. - March 04, 2017 - iHealthcareAnalyst, Inc.
Global Enteric Disease Testing Market Analysis: Bacterial-, Viral-, and Parasitic Agents and Forecast to 2020, New Research by iHealthcareAnalyst, Inc.
Enteric Disease Testing Market by Causal Organism for Enteric Disease Type (Bacterial Agents – C. difficile, Campylobacteriosis, Cholera, E. coli, H. pylori, Salmonellosis, Shigellosis; Viral Agents – Norovirus, Rotavirus; and Parasitic Agents – Amebiasis, Cryptosporidiosis, Giardiasis) 2016-2020 - February 18, 2017 - iHealthcareAnalyst, Inc.
Agenda Released for SMi’s Pharmaceutical Microbiology USA Conference
The agenda has been released and registration is now open for SMi’s Pharmaceutical Microbiology USA show. The seventh in its series, this event will take place in San Diego, on the 8th and 9th June 2017. - February 16, 2017 - SAE Media Group
Psoriasis Treatment Market Precise Industry Analysis and Growth Trends Forecasted for 2016 to 2024, TMR Study
Report presents a brief overview of the global market along with psoriasis treatment .It also provides information and data analysis of the global market with respect to the segments based on products, distribution channel, therapy type and geography. - February 03, 2017 - Market Research Hub
Advent of Pipeline Products for Rheumatoid Arthritis Expected to Change Substantially Its Market Landscape
Report titled "Rheumatoid Arthritis" has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. - February 01, 2017 - Market Research Hub
G&L Scientific Inc. Announces Opening of New Offices in Cambridge, Massachusetts
G&L Scientific Inc, the leading provider of clinical and scientific consulting and resource to the healthcare industry (http://www.gandlscientific.com), has announced the opening of new offices in Cambridge, Massachusetts, strengthening and improving access to its expanding team of clinical and scientific consultants and contractors. This is the latest step in G&L’s expansion of its global clinical consulting services throughout the United States. - January 19, 2017 - G&L Scientific Inc
A Big Pharma Update on Fighting Superbugs: GSK Report Industry Developments in Addressing AMR
SMi Reports: Superbugs & Superdrugs 2017 returns to Central London for its 19th Annual Show this March. - January 12, 2017 - SAE Media Group
Tuberculosis Pipeline Landscape and Therapeutics Market Review for H2 2016
Report provides broad information on the therapeutics under development for tuberculosis globally. This covers the descriptive pharmacological action of the therapeutics with its complete research & development history. - December 02, 2016 - Market Research Hub
FDA Exclusive: a Spotlight on Regulation in Antibacterial Drug Development
FDA Division of Anti-Infective Products Director, Sumathi Nambair, due to Present at Superbugs & Superdrugs 2017. - December 02, 2016 - SAE Media Group
Global Hospital-Acquired Pneumonia Drugs (Phase III) Market USD 3.8 Billion by 2020, Research Study by iHealthcareAnalyst, Inc.
The global hospital-acquired pneumonia drugs (Phase III) market is estimated to reach USD 3.8 Billion in 2020, published by iHealthcareAnalyst, Inc. Visit the Hospital-Acquired Pneumonia Drugs (Phase III) Market – Amikacin Inhale, Ceftazidime (Avibactum), Ceftolozane (Tazobactam),... - December 01, 2016 - iHealthcareAnalyst, Inc.
Pipeline Market Review on Therapeutic Landscape of Rubella (German Measles) H2 2016
Report offers a brief overview about German measles disease and its therapeutic development. It is an infectious disease caused by a virus called “Rubella.” This directly infects the skin and lymph nodes. The main symptom is a pink spotty rash that starts from the face and spreads to the arms & chest. - November 26, 2016 - Market Research Hub
Global Cancer Technology, Inc. Signs Licensing Agreement with the University of California San Diego
Announcing an agreement to purchase patent and IP technology from UCSD for a novel way to track medical instruments using Nano Quantum Dots - November 25, 2016 - Global Cancer Technology, Inc
The Consortium of Sterile Sciences
As complex surgical instruments replace simpler surgical instruments for minimally invasive surgery and faster recovery time for patients, advanced education is required to insure the sterile processing of these complex surgical instruments. Sadly, 290,000 patients suffer surgical site infections mostly from the use of contaminated surgical instruments every year. From a layman’s perspective, 800 Americans will suffer surgical site infections today - some will not make it. - October 14, 2016 - The Consortium of Sterile Sciences
Rentokil Malaysia Battling Rising Dengue and Zika Cases with Integrated Mosquito Management Programme
Besides the high number of dengue cases in Malaysia, Zika infections have also started to emerge locally. Learn what could be the main contributory factors and what can be done to curb this. - October 10, 2016 - Rentokil Initial
IQ4I Research & Consultancy Published a New Report on “Infection Control Global Market – Forecast To 2022”
Infection control is policies and procedures followed to minimize the threat of acquiring, spreading infections, especially in hospitals and other healthcare facilities. Healthcare-acquired infections (HCAI) continue to be a major safety concern for both health care providers and the patients, thus prevention and control of healthcare-associated infections remains a priority. - September 24, 2016 - IQ4I Research & Consultancy Pvt. Ltd.
Rower Releases US 4.5 Million Spirit of Malabo Rowboat to Equatorial Guinea
After the UNGA, H.E. Anatolio Ndong Mba, Ambassador for the Permanent Mission of Equatorial Guinea will begin the process of gifting the rowboat to the UN. - September 24, 2016 - GC Media
Hepatitis B Foundation Launches Comprehensive New Website to Celebrate 25th Anniversary
National nonprofit’s new website offers improved user experience, simplified navigation as a trusted global authority for information about hepatitis B. - September 24, 2016 - Hepatitis B Foundation